Skip to main content
Fig. 2 | BMC Infectious Diseases

Fig. 2

From: Vaginal colonisation by probiotic lactobacilli and clinical outcome in women conventionally treated for bacterial vaginosis and yeast infection

Fig. 2

Frequency of isolation of EcoVag® and other Lactobacillus strains during the treatment of BV and VVC. The frequency of isolation (y axis) was determined as the percentage of samples positive for EcoVag® strains or other lactobacilli on the total number of samples for each group. Trial I: women treated for BV with antibiotics and EcoVag® (BV EcoVag®). Trial II: women treated for BV with antibiotics and prolonged administration of EcoVag® (BV EcoVag®), women treated for VVC with fluconazole and prolonged administration of EcoVag® (VVC EcoVag®), women treated for VVC with fluconazole only (VVC fluconazole). The difference in frequency of isolation of EcoVag® strains or other lactobacilli between groups was compared by Fisher’s exact test. *** P < 0.001

Back to article page